Despite current therapeutic strategies for immunomodulation and relief of symptoms in multiple sclerosis (MS), remyelination falls short due to dynamic...
Abstract Objective: We studied our collective open-label, compassionate use experience in using cannabidiol (CBD) to treat epilepsy in patients with...
Neural hyperexcitability in the event of damage during early life, such as hyperthermia, hypoxia, traumatic brain injury, status epilepticus, or...
Abstract Background: The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a high...
The isolation and identification of the discrete plant cannabinoids in marijuana revived interest in analyzing historical therapeutic claims made for...
Cannabidiol (CBD) products are widely marketed to horse owners, trainers, and veterinarians and are readily available to the consumer despite...
Thirty stock type geldings (15 ± 3 years; 556 ± 63 kg BW) were used in a randomized complete design...
Abstract Background: The endocannabinoid system (ECS) is composed of cannabinoid receptors type 1 (CBR1) and type 2 (CBR2), cannabinoid-based ligands...
Osteoarticular equine disease is a common cause of malady; in general, its therapy is supported on steroids and nonsteroidal anti-inflammatories....
Abstract In recent years, interest in hemp use has grown owing to its chemical and medicinal properties. Several parts of...
© 2025 · Veterinary Cannabis Society